Tyme Investor Relations Material
Latest events
Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies Inc was a biotechnology company that developed cancer metabolism-based therapies aimed at targeting and disrupting cancer cell metabolism. The company focused on developing novel therapeutic candidates for the treatment of various types of cancer. Tyme Technologies served the oncology sector through research-driven initiatives. The company was headquartered in Bedminster, New Jersey, and its shares were listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TYME
Country
🇺🇸 United States